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Abstract
Background: In June 2009, the World Health Organization declared an A(H1N1) influenza pandemic. In October
2009, the largest vaccination campaign in Canadian history began. The aim of this study was to document
paediatricians’ knowledge, attitudes and practices (KAP) regarding A(H1N1) pandemic influenza and its prevention
by vaccination just after the beginning of the A(H1N1) vaccination campaign and to compare the results with
those obtained before campaign initiation.
Methods: A self-administered mail-based questionnaire was sent to all Canadian paediatricians. Questionnaires
were analyzed in two subsets: those received before and after the beginning of the vaccination campaign.
Results: Overall the response rate was 50%. Respondents’ characteristics were comparable between the two subsets.
Before the beginning of the campaign, 63% of paediatricians perceived A(H1N1) pandemic infection as a serious
disease, that would occur frequently without vaccination compared to more than 75% after. Before the vaccination
campaign, half of respondents or less thought that the A(H1N1) vaccine was safe (50%) and effective (35%) compared
to 77% and 72% after. The proportion of paediatricians who reported they had received sufficient information on A
(H1N1) vaccine increased from 31% before to 73% after the beginning of the vaccination campaign. The majority of
respondents intended to get vaccinated against A(H1N1) influenza themselves (84% before and 92% after).
Respondents’ intention to recommend the A(H1N1) vaccine to their patients increased from 80% before the beginning
of the campaign to 92% after. In multivariate analysis, the main determinants of paediatricians’ intention to recommend
the A(H1N1) vaccine were their intention to get vaccinated against A(H1N1) influenza themselves and a belief that A
(H1N1) vaccine would be well accepted by health professionals who administer vaccines to the public.
Conclusion: Results of this study show important increases in physicians’ level of confidence about A(H1N1)
vaccine’s safety and immunogenicity and their willingness to recommend this vaccine to their patients. These
changes could be explained, at least partially, by the important effort done by public health authorities to
disseminate information regarding A(H1N1) vaccination.
Background
In June 2009, the World Health Organization (WHO)
declared an A(H1N1) influenza pandemic [1]. In Octo-
ber 2009, the largest vaccination campaign in Canadian
history began. Before the start of the A(H1N1) pan-
demic influenza vaccination campaign, limited
i n f o r m a t i o no nt h es a f e t yand immunogenicity of A
(H1N1) influenza vaccines was available. However, the
spread of A(H1N1) influenza generated intense media
interest in pandemic preparedness and contradictory
information around the vaccine and the vaccination
campaign was reported [2-6]. During the first wave of A
(H1N1) influenza in Canada, 77 deaths were reported,
mostly in the provinces of Quebec and Ontario. During
the second wave, in early fall 2009, 351 deaths were
reported across the country [7]. In Canada, almost
* Correspondence: eve.dube@ssss.gouv.qc.ca
1Institut National de Santé publique du Québec, 2400 d’Estimauville, Québec,
Canada
Full list of author information is available at the end of the article
Dubé et al. BMC Public Health 2011, 11:128
http://www.biomedcentral.com/1471-2458/11/128
© 2011 Dubé et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.exclusively, an A(H1N1) pandemic influenza vaccine
(Arepanrix™) containing a novel adjuvant (AS03 adju-
vant, as an oil-in-water emulsion) was used [8].
Physicians are known to play a key role in public
acceptance of new vaccines and their recommendations
are an important determinant of vaccine uptake [9-13].
Prior to the A(H1N1) vaccine approval for clinical use
and the release of professional association and experts
committee recommendations, we documented Canadian
family physicians’ and paediatricians’ knowledge, atti-
tudes and practice (KAP) regarding A(H1N1) pandemic
influenza and its prevention by vaccination [14]. In this
study, 59% of paediatricians had had some experience
with severe cases of A(H1N1) pandemic influenza and
the majority (75%) of them were willing to recommend
the A(H1N1) pandemic vaccine to their patients. More
than 75% of the respondents also indicated the willing-
ness to get the vaccine themselves [14].
The aim of this study was to document paediatricians’
KAP regarding A(H1N1) pandemic influenza and its
prevention by vaccination just after the beginning of the
A(H1N1) vaccination campaign and to compare these
results with those obtained before vaccination campaign
initiation.
Methods
A self-administered, anonymous, mail-based question-
naire was sent to all Canadian paediatricians, except
subspecialist. The Canadian Medical Directory [15]
was used to identify paediatricians. This database con-
tains more than 58,000 listings of Canadian physicians
medical contact information and is updated each year.
A multidisciplinary team developed the questionnaire
using the Analytical framework for immunization
programs in Canada as a theoretical base [16]. This
framework was developed to guide and standardize pub-
lic health decision-making process regarding new immu-
nization programs in Canada. It includes 58 criteria
classified into 13 categories. Three categories of this
framework were used to guide the construction of the
questionnaire: (1) Burden of disease, (2) Vaccine charac-
teristics, and (3) Acceptability of the vaccine program.
The final questionnaire included 12 questions on A
(H1N1) pandemic influenza and its prevention by vacci-
nation as well as 10 questions on KAP about vaccination
in general and 10 questions on demographic and profes-
sional characteristics of respondents. Respondents were
asked to base their answers on their own knowledge
and opinions. For most questions, a 6-point Likert
answer scale ranging from “strongly disagree” to
“strongly agree” was used. No information on A(H1N1)
pandemic influenza or the vaccines was provided. The
questionnaire was mailed to 1,852 pediatricians. The
first two mailings were done in August-September 2009
and the third in November 2009. The last mailing was
sent to 1,118 pediatricians who had not responded to
the first two mailings. The study protocol was approved
by the Ethics Board of the Laval University Hospital
Center (reference number 126.05.02).
All vaccines authorized for sale in Canada, including
the A(H1N1) influenza vaccines, are reviewed and
approved by the federal government (Health Canada).
However, each province and territory is responsible for
the development of publicly funded immunization pro-
grams, including the schedules and the logistics of
administering vaccines as well as education of the popu-
lation and health professionals. The A(H1N1) pandemic
vaccine was approved for use in Canada on 21
st October
2009 and vaccination campaign started shortly after-
wards in all Canadian provinces and territories (within
days before or after 29
th October 2009). To vaccinate as
many persons as possible in the shortest period of time,
most Canadian jurisdictions used mass vaccination cen-
tres administered by the public system. All provincial
and territorial authorities, conjointly with federal autho-
rities, have determined a sequence of vaccination by tar-
get groups. Throughout Canada, priority to receive the
A(H1N1) vaccine was given to healthcare workers. Mass
vaccination campaign ended in most Canadian provinces
and territories in mid-December 2009.
Due to the intense media coverage and the important
educational efforts undertaken around the vaccination
campaign and their potential impact on physicians’ KAP
[17,18], we decided to perform a “before-after” analysis.
Questionnaires were analyzed in two subsets: those
received before (first subset) and after (second subset)
the start of the vaccination campaign (October 29).
Descriptive statistics were generated for all variables.
Missing responses were excluded from the analyses.
Univariate analyses were computed separately for the
two data subsets. Comparisons of categorical responses
were performed using chi-square or Fisher’s exact tests.
A multivariate logistic regression model was used to
determine variables independently associated with the
paediatrician’s intention to recommend the A(H1N1)
pandemic vaccine. Dependent and explanatory variables
were dichotomized: the responses “strongly agree” and
“agree” versus all others ("strongly disagree”, “disagree”,
“somewhat disagree” and “somewhat agree”). Variables
associated in the univariate analysis with the intention
to recommend the vaccine at p ≤ 0.20 were entered into
the multivariate regression models using the stepwise
selection technique. The model was adjusted to take
into consideration the two subsets of data. A new binary
explanatory variable was created (subsequently referred
to as “subset variable”) and forced into the model: ques-
tionnaires mailed before the beginning of the vaccina-
tion campaign and questionnaires mailed after. Variables
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founding and model fit. A probability level of p < 0.05
based on two-sided tests was considered statistically sig-
nificant. The collinearity was checked and the adequacy
of the model was evaluated by Hosmer and Lemeshow’s
goodness of fit test.
Multiple correspondence analysis (MCA) method [19]
w a sa l s ou s e da sac o m p l e m e n tary way to analyse our
dataset. MCA is used to detect links between variables
(including, in this study, the intention to recommend
the A(H1N1) vaccine), but there is no dependent vari-
able. This method is a form of principal components
analysis that is appropriate for qualitative variables.
MCA searches for principal components, which are new
quantitative modelled variables, constructed as linear
functions of the initial variables. Finding the principal
components is based on the maximisation of the corre-
lation ratio between the principal component and the
initial variables. All principal components are mutually
uncorrelated by construction. Our initial variables were
all variables in the questionnaire pertaining to A(H1N1)
vaccine and A(H1N1) influenza and the subset variable.
Analysis was computed using the raw variables (6
degrees of answers ranging from “Strongly agree” to
“Strongly disagree”). We carried out this MCA as a sen-
sitivity analysis to better assess the role of the subset
variable and the impact of all 6 degrees of possible
answers on the Likert scale. The Statistical Analysis Sys-
tems (SAS
®) software (version 9.2 of the SAS system for
Windows. Copyright (c) 2002-2008 by SAS Institute
Inc., Cary, NC, USA) and R software (version 2.11.1)
[20] with the library FactoMineR [21] were used for
data analyses.
Results
Participation and socio-professionals characteristics
Overall, 912 paediatricians have completed the question-
naires: 714 completed the questionnaire before the
beginning of the A(H1N1) vaccination campaign and
197 completed it after. After exclusion of physicians no
longer practicing, those with incorrect addresses or
those who were subspecialists, the overall participation
rate was 50% (911/1832). Participation rates by country
regions varied from 40.1% in Prairies to 57.7% in Que-
bec. Table 1 shows respondents’ socio-professionals
characteristics. No statistically significant differences
were found among the characteristics of paediatricians
who complete the survey before and after the beginning
of A(H1N1) vaccination campaign.
Knowledge, attitudes and practices regarding vaccination
in general
Overall, 98% of paediatrician st h o u g h tt h a tv a c c i n e s
recommended by public health authorities are very
useful (97,6% before and 98,5% after; p = 0,5911), and
73% agreed or strongly agreed with the statement “it is
very useful to protect children with the vaccines against
seasonal influenza” (72,9% before and 73,9% after; p =
0,7855). When recommending new vaccines to their
patients, 91% of paediatricians indicated that they are
highly influenced by expert group recommendations
(91,3% before and 90,7% after; p = 0,8152) and 90%, by
professional association recommendations (90,8% before
and 89,7% after; p = 0,6414). Approximately half of pae-
diatricians (49%) stated that it is easy for them to advise
their patients on new vaccines. No statistically signifi-
cant differences were found in attitudes towards vacci-
nation in general between respondents who answered
before or after the beginning of A(H1N1) vaccination
campaign
Knowledge, attitudes and practices regarding A(H1N1)
pandemic influenza and its prevention by vaccination
Before the beginning of the campaign, 63% of paediatri-
cians perceived A(H1N1) pandemic infection as a ser-
ious disease, that would occur frequently without
vaccination comparatively to more than 75% after cam-
paign initiation. In addition, less respondents considered
that A(H1N1) pandemic influenza was severe enough to
take special precautions to prevent it before, than after
the start of the vaccination campaign (73% agreed or
strongly agreed before compared to 63% after, p =
0.0136) (Table 2). Before the vaccination campaign, half
of respondents or less agreed or strongly agreed that the
A(H1N1) vaccine was safe (50%) and effective (35%)
compared to 77% and 72% after the start of the cam-
paign who felt the vaccine was safe and effective (p <
0.001) (Table 2). Paediatricians’ perceived acceptability
of A(H1N1) vaccine by the public remained comparable
(45% before versus 41% after agreed and strongly agreed,
p = 0.3608). Paediatricians’ perceived acceptability of the
A(H1N1) vaccine by health professionals who adminis-
tered vaccines (hereafter named “vaccine providers”)
increased after the beginning of vaccination campaign
(71% before versus 84% after, p < 0.001). Respondents’
intention to recommend the A(H1N1) vaccine increased
from 80% before the beginning of the campaign to 92%
after, including 46% and 62% of paediatricians that
declared they would strongly recommend it, respectively.
Globally, 40% of respondents who disagreed with the
usefulness to protect children with the seasonal influ-
enza vaccine did not intended to recommend A(H1N1)
pandemic vaccine to their patients while 2% of physi-
cians who agreed with the usefulness of the seasonal
influenza vaccine did not intended to recommend the A
(H1N1) pandemic vaccine (p < 0.001) (data not shown).
The majority of respondents intended to get vaccinated
against A(H1N1) pandemic influenza themselves (84%
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cally significant differences were observed in intention
to be vaccinated between paediatricians practicing in
different Canadian regions, neither before (p = 0.4315)
nor after (p = 0.4291) the beginning of the campaign.
Before the beginning of the vaccination campaign, 13%
of paediatricians were undecided about being vaccinated
themselves compared to 3% after. Finally, the proportion
of paediatricians who reported they had received suffi-
cient information on A(H1N1) vaccine increased from
31% before the beginning of the campaign to 73% after
(p < 0.001), with 3% of respondents reporting they felt
their knowledge was insufficient after the beginning of
the vaccination campaign versus 17% before (Table 2).
Factors associated with the intention to recommend A
(H1N1) pandemic vaccine before and after the start of the
vaccination campaign
The intention to get vaccinated against A(H1N1) pan-
demic influenza themselves (OR = 8.65) and belief that
A(H1N1) pandemic vaccine would be well accepted by
vaccine providers (OR = 6.65) were the most significant
factors associated with the intention to recommend A
(H1N1) pandemic vaccine to patients. Six other vari-
ables were also significantly associated with the inten-
tion to recommend the vaccine: belief that seasonal
influenza vaccines are very useful to protect child health;
perceived economic burden of A(H1N1) influenza ill-
ness; self-estimated sufficiency of knowledge about the
A(H1N1) vaccine; perceived safety of the A(H1N1) vac-
cine; perceived severity of A(H1N1) pandemic influenza
and belief that special precautions to prevent A(H1N1)
pandemic influenza are needed (Table 3).
Multiple correspondence analyses (MCA)
Results of MCA supported the associations found in the
logistic regression models (Figure 1). Overall, first and
second principal components summarized 13.6% of the
initial variables’ variability. The coefficients of determina-
tion (r
2) for the first and second principal components
Table 1 Paediatricians’ professional and demographic characteristics (%)
Characteristics Before N = 714 After N = 197 P-value
Sex
Male 41.9 46.7 0.2327
Location of main practice
Private office 44.6 42.3
Hospital 51.8 52.1 0.4371
Other 3.7 5.7
Number of hours in outpatient consultation
<7 hours 16.7 24.9 ’>21 hrs’ vs. others:
From 7 to 21 hours 28.8 26.5
>21 hours 54.5 48.6 0.1571
Number of doses of vaccines administered each month in respondents’ main
practice place
None 42.1 48.9
<30 doses 29.5 30.9 None vs. others:
0.0924
From 30 to 100 doses 13.1 6.4
>100 doses 15.3 13.8
Number of years of practice
>20 years 39.6 37.9
From 10 to 20 years 37.2 40.5 0.6915
<10 years 23.2 21.6
Provinces of practice
Atlantic 9 7.2
Quebec 29.6 22.2
Ontario 35.1 40.7 0.2067
Prairies 16.2 17.5
British Columbia 10.1 12.4
I am planning to get vaccinated against A(H1N1) pandemic influenza
Yes 83.9 92.3 0.0028
No - don’t know 16.2 7.7
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Before A(H1N1) vaccination
campaign
After A(H1N1) vaccination
campaign
A(H1N1) pandemic influenza...
Is severe enough to take special precautions to prevent it n = 704 n = 195
Somewhat agree 26.6 20.5
Agree 38.8 38
Strongly agree 24.3 34.9
Is a serious disease * n = 671 n = 193
Somewhat agree 28,2 16.6
Agree 37.7 43
Strongly agree 25 36.3
Would occur frequently in Canada without vaccination * n = 672 n = 190
Somewhat agree 25 14.2
Agree 36.9 36.8
Strongly agree 25.3 39
Generates a significant economic burden in Canada n = 682 n = 190
Somewhat agree 15.3 9.5
Agree 33.3 34.2
Strongly agree 46.6 51.1
In my medical practice or in my private life, I have had
experience with severe A(H1N1) pandemic influenza
n = 698 n = 193
Yes 59 81.3
A(H1N1) pandemic influenza vaccines will be/are...
Safe * n = 615 n = 186
Somewhat agree 42 20.4
Agree 34.3 45.7
Strongly agree 15.5 31.7
Effective * n = 590 n = 187
Somewhat agree 54.6 25.1
Agree 27.1 43.9
Strongly agree 7.5 28.3
Well accepted by the public n = 677 n = 187
Somewhat agree 35.9 41.2
Agree 29.4 34.2
Strongly agree 15.1 6.4
Well accepted by vaccine providers * n = 671 n = 188
Somewhat agree 22.8 12.2
Agree 39.5 46.8
Strongly agree 31.7 37.2
I consider that my knowledge on the pandemic influenza (H1N1) vaccine is
sufficient *
n = 690 n = 193
Somewhat agree 31 19.2
Agree 21 37.3
Strongly agree 10.4 35.2
I will recommend the A(H1N1) pandemic vaccine to my patients* n = 671 n = 189
Somewhat agree 15.7 5.8
Agree 33.8 29.1
Strongly agree 46.1 62.4
* Before/after differences statistically significant at p < 0.05.
Dubé et al. BMC Public Health 2011, 11:128
http://www.biomedcentral.com/1471-2458/11/128
Page 5 of 9were low (maximum at 0.71 for the first principal compo-
nents, and 0.57 for the second principal component). It
showed that responses were homogeneous among
respondents. More precisely, results showed that we
could group our respondents by negative levels rather
than positive levels of their answers: the levels “strongly
disagree” and “disagree” were the most discriminatory
levels.
Before and after the onset of the vaccination cam-
paign, the modelled principal component had the
respondents’ intention to recommend A(H1N1) pan-
demic vaccine as principal contributor (weight for the
“strongly disagree” level: 4.14). Then we found respon-
dent’s intention to receive A(H1N1) pandemic vaccine
(weight for the ‘no’ level: 3.45), and “belief that seasonal
influenza vaccines are very useful to protect children
health” (weight for the “strongly disagree” level: 3.44).
Mean of weight for all other variables is 0.87, including
the subset variable which was the less correlated variable
(variable S on figure 1) with first and second principal
components.
Discussion
To our knowledge, this is the first study that measured
changes in physicians’ KAP regarding A(H1N1) pan-
demic influenza and its prevention by vaccination before
and after the approval of the vaccine and start of the
vaccination campaign. Previous studies among health
care workers assessed acceptability of the A(H1N1) vac-
cine before its official approval and program implemen-
tation or used hypothetical pandemic vaccination
scenarios [18,22-26]. In these studies, intention to be
vaccinated against A(H1N1) pandemic influenza varied
from 48% to 80% among healthcare workers, compara-
tively to 84% of paediatricians surveyed before the
beginning of the vaccination campaign in our study.
Similarly to our results, a study done in Mexico
reported that 72% of healthcare workers would recom-
mend the vaccine to their patients, and they were more
likely to do so when they had the intention to get vacci-
nated themselves [25].
R e s u l t so ft h i sn a t i o n a ls u r vey among paediatricians
indicated an important increase in paediatricians percep-
tions of the burden of A(H1N1) pandemic influenza and
support for A(H1N1) vaccination after the beginning of
the vaccination campaign. Respondents’ endorsement of
almost all items regarding A(H1N1) pandemic influenza
and its prevention by vaccination increased after the
start of the vaccination campaign. This is not surprising
given the fact that the first A(H1N1) vaccine available in
Canada used a novel adjuvant (AS03) for which limited
information regarding the safety and immunogenicity
was available. The proportion of physicians who
reported they had received sufficient information about
A(H1N1) vaccine also increased by 42% after the start
of the vaccination campaign. This increase may be attri-
butable to the important educational efforts done at the
beginning of the vaccination campaign along with the
official recommendations by expert groups and profes-
sional associations that were released in early November
[27-29].
Health professionals’ knowledge about vaccines has
been previously shown as a main determinant associated
with their own vaccine uptake and their intention to
recommend the vaccine to their patients [30,31]. The
association between physicians own vaccination beha-
viours and their recommendations to their patients was
previously established [12,32-35]. It appears to hold true
in a pandemic context, as shown by our results and
those previously reported in Mexico [25].
Our results highlight the positive change in paediatri-
cians’ knowledge and level of support of the A(H1N1)
vaccines throughout the pandemic vaccination cam-
paign. This change may be attributable to increased
e d u c a t i o ne f f o r t sa n dt h ev e r yr a r ev a c c i n ea s s o c i a t e d
adverse events [36], but may also reflect the intense
media attention focused on the vaccination campaign.
A recent UK study has shown that healthcare workers
were more willing to accept stockpiled H5N1 vaccine
during a period of high media coverage of a H5N1 out-
break in a poultry farm than 6 months after (63.4% vs.
51.9%, p = 0.009) [18]. The increased exposure of
Table 3 Variables associated with respondents intention
to recommend A(H1N1) pandemic vaccine in multivariate
regression analysis (N = 709) *
Variables Adjusted
OR
95% CI P
value
Paediatricians’ intention to receive A
(H1N1) themselves
8.65 4.27-17.14 <0.0001
Belief
§ that A(H1N1) vaccine will be
well accepted by vaccine providers
6.60 3.70-11.76 <0.0001
Belief
§ that seasonal influenza
vaccines are very useful to protect
children health
2.84 1.58-5.10 0.0005
Belief
§ that A(H1N1) pandemic
influenza generate a significant
economic burden in Canada
2.78 1.51-5.08 0.0010
Self-estimated sufficiency of
knowledge on A(H1N1) vaccine
2.10 1.05-4.20 0.0351
Belief
§ that A(H1N1) vaccine will be
safe
2.10 1.13-3.90 0.0195
Belief
§ that A(H1N1) pandemic
influenza is a serious disease
2.09 1.13-3.88 0.0189
Belief
§ that A(H1N1) pandemic
influenza is a severe enough to take
special precautions to prevent it
1.88 1.04-3.42 0.0377
Subset variable (before = 1, after = 0) 0.84 0.36-1.96 0.6864
* Multivariate analyses; OR = odds ratio; CI = confidence interval; 205 physicians
were excluded because of missing answers (170 before and 32 after).
§ Strongly agree, agree.
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observed in our results, may also have enhanced paedia-
tricians’ acceptability of A(H1N1) pandemic vaccine.
In logistic regression analysis, paediatricians’ intention
to get vaccinated against A(H1N1) pandemic influenza
themselves was the most significant factor associated
with the intention to recommend A(H1N1) pandemic
vaccine to patients. Results obtained by the multiple
correspondence analysis (MCA) are consistent with
results from the logistic regression analysis. The nega-
tive levels were also more discriminatory than the posi-
tive ones. This is consistent with results of previous
studies that have shown that knowledge and behaviors
regarding seasonal influenza influenced A(H1N1) vacci-
nation status: individuals who were not vaccinated
against seasonal influenza were less likely to have the
Figure 1 Correlations’ graph between variables and the first and second principal components. Total percentage of the variability
explained by first and second principal components was 13.6%. Variables almost uncorrelated with first and second principal components aren’t
represented on the graph, except subset variable (S). The variables: B, C, F, G, J contributed more to first and second principal components than
others. - J: Respondent’s intention to recommend A(H1N1) pandemic vaccine to their patients - G: “Belief that A(H1N1) vaccine will be effective”
-F :“Belief that A(H1N1) vaccine will be safe” -C :“Belief that A(H1N1) pandemic influenza is a serious disease” -B :“Belief that seasonal influenza
vaccines are very useful to protect children health” All variables, including variables almost uncorrelated with first and second principal
component, are listed in an additional file (see Additional File 1).
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tion to be vaccinated against A(H1N1) pandemic influ-
enza was also higher than vaccine uptake against
seasonal influenza among healthcare workers usually
reported in Canadian studies [39,40], which was esti-
mated at 64% in 2006 [41]. In our study, a significant
proportion of paediatricians who disagreed with the use-
fulness to protect children with the seasonal influenza
vaccine did not intended to recommend the A(H1N1)
vaccine to their patients. However, results obtained by
MCA should be interpreted with precautions as only
13.6% of the variability is summarized by the first and
second principal components. This is principally due to
the uneven distribution of response levels.
Our study has several limitations. First, the study
wasn’t initially designed for a “before-after” analysis. The
increase in the willingness to be vaccinated against A
(H1N1) pandemic influenza observed among paediatri-
cians may result from a response bias of respondents
having more doubts about pandemic vaccination before
the vaccination campaign actually started. Nonetheless,
respondents’ demographic and professionals characteris-
tics as well as their attitudes toward vaccination in gen-
eral were very similar, thus suggesting the two subsets
of participants were comparable. Second, the dichotomi-
zation of the dependant variable ("strongly agree” and
“agree” versus all others) was a conservative choice and
physicians who answered “somewhat agree” were con-
sidered as having a neutral opinion, not a positive one.
Third, the repartition of the answers to the dependant
variable in the subset of data collected after the begin-
ning of the vaccination campaign did not allow us to
perform two multivariate analysis for the two subset.
However, the model was adjusted to take into consid-
eration the time period when the paediatricians com-
pleted the survey (before or after the initiation of the
campaign). Finally, the response rate was 50% and a
non-participation bias cannot be excluded. However, the
response rate remains satisfactory for a mail-based sur-
vey with physicians [42-44]. In addition, socio-demo-
graphic characteristics of respondents are comparable to
those reported in other surveys conducted among Cana-
dian paediatricians [42,45]. Socio-professional character-
istics of respondents also allow us to suppose a good
representativeness.
Results of this study indicated a high level of paedia-
tricians willingness to be vaccinated against A(H1N1)
and to recommend the vaccine to their patients. Lack of
knowledge on A(H1N1) vaccine, belief that A(H1N1)
was not a severe disease as well as concerns over A
(H1N1) vaccine safety and usefulness were barriers to
paediatricians’ intention to recommend it. This is con-
sistent with barriers to seasonal influenza vaccination
among healthcare workers reported in the literature
[31,46,47]. Public health interventions to promote seaso-
nal influenza vaccination among healthcare workers
should include the delivery of evidence-based informa-
tion regarding influenza vaccines’ safety, efficacy and
usefulness. Educational campaigns should also stress out
the threat posed by seasonal influenza to healthcare
workers and the patients.
Conclusion
In summary, the results show the important increases in
physicians’ level of confidence about A(H1N1) vaccine
safety and immunogenicity and their willingness to
recommend this vaccine during the first months of the
campaign. More than 40% of all Canadians aged 12 years
or older received at least one dose of the A(H1N1) vac-
cine during the vaccination campaign [48]. In the pro-
vince of Quebec, Canada, almost 80% of the children
aged between 6 months and 5 years were vaccinated
against A(H1N1) influenza [49]. Paediatricians’ support
of the vaccination campaign and their recommendations
were surely one of the key components of such a success.
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